Takeda: TAK-019 (Novavax formulation)

Vaccine Type: Protein Subunit

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 1 Trial

Phase 2: 1 Trial

Phase 3: 1 Trial

Approvals

1 Country

This vaccine is the same formulation as the Novavax vaccine (NVX-CoV2373)

Registered Trials